After 3 or 4 doses, mRNA-based COVID-19 vaccines are similarly effective in patients with cancer and the general population, a study suggests.
Leah Lawrence
Leah Lawrence is a freelance health writer and editor based in Delaware. She has contributed to trade, consumer, and medical association publications and websites focused on hematology/oncology, cardiology, primary care, endocrinology, and general health.
